Canton Strategic Holdings (CNTN) Prepaid Assets (2020 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Prepaid Assets came in at $1.6 million in Q1 2026, up 231.6% YoY from $468366.0 in Q1 2025, and up 339.58% on a QoQ basis from $353318.0 in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Prepaid Assets (2020 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 7 years of Prepaid Assets data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Prepaid Assets rose 231.6% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 231.6% YoY) and the FY2025 annual result came in at $353318.0, up 680.59% from the prior year.
- Prepaid Assets improved to $1.6 million in Q1 2026, from $353318.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.6 million in Q1 2026 to a low of $11041.0 in Q4 2023.
- A 5-year average of $498031.1 and a median of $421590.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 93.8% — and 2025, when it jumped 680.59%.
- Tracing CNTN's Prepaid Assets over 5 years: stood at $178094.0 in 2022, then sank by 93.8% to $11041.0 in 2023, then soared by 309.95% to $45263.0 in 2024, then jumped by 680.59% to $353318.0 in 2025, then jumped by 339.58% to $1.6 million in 2026.
- The last three Prepaid Assets figures came in at $1.6 million (Q1 2026), $353318.0 (Q4 2025), and $89038.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.27 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 197,383.00 |
| Sep 30, 2025 | 89,038.00 |
| Jun 30, 2025 | 196,018.00 |
| Mar 31, 2025 | 468,366.00 |
| Dec 31, 2024 | 45,263.00 |
| Sep 30, 2024 | 477,009.00 |
| Jun 30, 2024 | 301,620.00 |
| Mar 31, 2024 | 460,007.00 |
| Dec 31, 2023 | 11,041.00 |
| Sep 30, 2023 | 412,890.00 |
| Jun 30, 2023 | 695,375.00 |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 178,094.00 |
| Sep 30, 2022 | 421,590.00 |
| Jun 30, 2022 | 763,443.00 |
| Mar 31, 2022 | 969,289.00 |
| Dec 31, 2021 | 70,670.00 |
| Dec 31, 2020 | 102,946.00 |